Fetal hemoglobin in preeclampsia: a new causative factor, a tool for prediction/diagnosis and a potential target for therapy.

Research output: Contribution to journalReview articlepeer-review

Abstract

Preeclampsia, one of the leading causes of pregnancy complications, affects 3-7% of pregnant women. This review summarizes the present knowledge of a new potential cause of the disease and suggests a method for its prediction/diagnosis and a possible treatment, both based on the recent findings on the involvement of fetal hemoglobin (HbF) and the heme and radical scavenging protein A1M (alpha-1-microglobulin).
Original languageEnglish
Pages (from-to)448-455
JournalCurrent Opinion in Obstetrics & Gynecology
Volume25
Issue number6
DOIs
Publication statusPublished - 2013

Subject classification (UKÄ)

  • Obstetrics, Gynecology and Reproductive Medicine

Fingerprint

Dive into the research topics of 'Fetal hemoglobin in preeclampsia: a new causative factor, a tool for prediction/diagnosis and a potential target for therapy.'. Together they form a unique fingerprint.

Cite this